- Home
- APLT vs SSRM Comparison
APLT vs SSRM Comparison
Compare APLT & SSRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- SSRM
- Stock Information
- Founded
- APLT 2016
- SSRM 1946
- Country
- APLT United States
- SSRM United States
- Employees
- APLT 32
- SSRM N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- SSRM Precious Metals
- Sector
- APLT Health Care
- SSRM Industrials
- Exchange
- APLT Nasdaq
- SSRM Nasdaq
- Market Cap
- APLT 63.6M
- SSRM 4.3B
- IPO Year
- APLT 2019
- SSRM 1996
- Fundamental
- Price
- APLT $0.42
- SSRM $22.39
- Analyst Decision
- APLT Buy
- SSRM Buy
- Analyst Count
- APLT 6
- SSRM 3
- Target Price
- APLT $6.10
- SSRM $12.23
- AVG Volume (30 Days)
- APLT 859.9K
- SSRM 3.5M
- Earning Date
- APLT 11-06-2025
- SSRM 11-05-2025
- Dividend Yield
- APLT N/A
- SSRM N/A
- EPS Growth
- APLT N/A
- SSRM N/A
- EPS
- APLT N/A
- SSRM 0.80
- Revenue
- APLT $121,000.00
- SSRM $1,302,616,000.00
- Revenue This Year
- APLT N/A
- SSRM $54.08
- Revenue Next Year
- APLT $5,931.24
- SSRM $16.62
- P/E Ratio
- APLT N/A
- SSRM $28.00
- Revenue Growth
- APLT N/A
- SSRM 6.22
- 52 Week Low
- APLT $0.30
- SSRM $5.06
- 52 Week High
- APLT $10.62
- SSRM $23.07
- Technical
- Relative Strength Index (RSI)
- APLT 38.92
- SSRM 81.90
- Support Level
- APLT $0.43
- SSRM $20.82
- Resistance Level
- APLT $0.46
- SSRM $21.69
- Average True Range (ATR)
- APLT 0.03
- SSRM 0.76
- MACD
- APLT -0.01
- SSRM 0.21
- Stochastic Oscillator
- APLT 0.35
- SSRM 88.57
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About SSRM SSR Mining Inc.
SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.